Hosted by Shriya Bhat, Harvard BCI · 🇺🇸 US · EN · 21 episodes
Established thought leaders with verified media credentials.
The Bio Accelerationism (bio/acc) podcast. Deeply researched interviews about fascinating topics from biotech and research.Podcast hosted by Shriya Bhat, a Harvard Sophomore from the Harvard Bioethics Communication Initiative (BCI).
Shriya Bhat, Harvard BCI hosts bio/acc Podcast, a science show with 21 episodes published.
Jay Rosanelli is the CEO and Co-Founder of Syenex, a biotech developing a platform for in vivo gene therapy delivery. While capital in the gene and cell therapy (CGT) space has grown over the last 5 years, there remain s
Show notesMichael Koeris is the Director of the Biological Technologies Office at DARPA, where he leads some of America's most cutting-edge biological research programs for defense. In this conversation, we discuss how AI is trans
Show notesIn this episode, I sit down with Jeff Coller, a professor at the Johns Hopkins University School of Medicine, about how decades of foundational RNA biology laid the groundwork for mRNA vaccines--and what comes next for m
Show notesIn this episode, I talk with John Quain, bioethics fellow at the Icahn School of Medicine and lead bioethicist at Manhattan Genomics. We talk about the ethics behind AI, germline editing, and the next wave of biotechnolo
Show notesIn this episode, biotech founder Cathy Tie unpacks the realities of building in regulated industries and the promise of gene editing done right. From unicorns and dragons to disease-free babies, we explore the technical,
Show notesIn this episode, I sit down with Aubrey de Grey, one of the leading voices in longevity science, and Benji Leibowitz, founder of Pump Science, to explore two visions of the future: longevity escape velocity and scientifi
Show notesIn this episode, I talk to Charles Brenner, a leading biochemist and outspoken critic of hype in the longevity field. We discuss why many aging studies in model organisms don’t always translate to humans, the limitations
Show notesIn this episode, I talk to James Sinka, a YC 3-time founder who believes that biotech on-chain will be the next revolution in funding for academic projects. We discuss the challenges of being a deep-tech founder, the int
Show notesIn this episode, biotech founder Cathy Tie unpacks the realities of building in regulated industries and the promise of gene editing done right. From unicorns and dragons to disease-free babies, we explore the technical,
Show notesIn this episode, I talk to Ethan Perlstein, a YC biotech founder who wants to make better drugs and financial incentives for curing rare diseases. We discuss the post-academic collapse in science careers, the financial a
Show notesIn this episode, I speak with Professor Francoise Baylis, a renowned Canadian bioethicist whose work lies at the intersection of applied ethics, health policy, and practice. We talk about the ethics of research on human
Show notesIn this episode, I speak with George Church—pioneer of human genome sequencing, co-inventor of CRISPR, and founder of over 50 biotech startups—on the future of synthetic biology: virus-proof cells, multiplex gene editing
Show notesIn this episode, I speak with award-winning NYT science writer Carl Zimmer (“Life’s Edge”, “She Has Her Mother’s Laugh”) on the verbs of biology—homeostasis, life being organized rebellion against entropy, and whether br
Show notesIn this episode, I talk with Jamie Metzl — geopolitical futurist, former WHO advisor, and author of Superconvergence — about the future of gene editing, AGI, and the existential risks no one is talking about. We cover CR
Show notesIn this episode, I talk with Dr. Aubrey de Grey, a leading researcher in the longevity space and co-founder of the SENS Research Foundation, known for his groundbreaking work in developing therapies that reverse DNA dama
Show notesIn this episode, I talk with Dr. Robert Langer, co-founder of Moderna and PI of the world’s largest biomedical engineering lab at MIT. We talk about his background, how to raise money for biotech ventures, and whether in
Show notesIn this episode, I talk with Dr. He Jiankui, a gene editing pioneer who used CRISPR/Cas technology to edit the infamous twin babies Lulu and Nana. We talk about his goals, ethics behind the technology, and the potential
Show notes
Dr. Victor Nizet, Professor of Pediatrics and Vice Chair for Basic Research at UC San Diego details some of the innovative approaches being used in his lab to fight infectious disease, namely, host-targeted immune based
Show notesDr. Nathan, a leading expert in microbiology and immunology, summarizes one of the most pressing problems in medicine: antimicrobial resistance. We discuss the evolution of drug resistance pathogens as well as the scient
Show notesDr. Stanley Plotkin is often hailed as the ‘Godfather of Vaccines.’ His pioneering work has not only led to the development of the rubella vaccine—critical in eradicating rubella across the Americas—but also propelled br
Show notesSponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch bio/acc Podcast, visit https://bioacceleration.com for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent science coverage.
bio/acc Podcast is hosted by Shriya Bhat, Harvard BCI. The show is categorised under science and has published 21 episodes.
bio/acc Podcast has published 21 episodes.
bio/acc Podcast regularly covers science. It sits in the science category.
bio/acc Podcast is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
bio/acc Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of bio/acc Podcast average 44 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates bio/acc Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 12 days ago.
